Enzymotec Ltd. (ENZY) Gross Profit Margin starting from the fourth quarter 2016 to fourth quarter 2015, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Enzymotec Ltd.  (ENZY)


Enzymotec Ltd.'s Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENZY Gross Profit Margin (Dec 31 2016)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2015)
Q4
Y / Y Revenue Change -5.35 %
Seq. Revenue Change -
Revenue In Millions $47.70
Gross Profit Margin 62.87 %
Gross Profit Margin Total Ranking # 1164
Gross Profit In Millions $29.99
Y / Y Gross Profit Change -2.5 %
Seq. Gross Profit Change -


Commenting fourth quarter 2016 Gross Profit Margin



Observing fourth quarter 2016 results within Biotechnology & Pharmaceuticals industry 16 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1164.
Learn about Gross Margin
ENZY's Gross Profit Margin fourth quarter 2016 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 164
Overall # 1022

Gross Profit Margin Statistics
High Average Low
62.87 % 61.67 % 61.03 %
(Dec 31 2016)   (Dec 31 2015)


ENZY Gross Income Trends • More of ENZY's Profitabilty Ratios • ENZY Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ENZY's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ENZY's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ENZY's Competitors
Gross Profit Margin Profit Margin for Enzymotec Ltd.'s Suppliers
Gross Profit Margin Profit Margin for ENZY's Customers

You may also want to know
ENZY's Annual Growth Rates ENZY's Profitability Ratios ENZY's Asset Turnover Ratio ENZY's Dividend Growth
ENZY's Roe ENZY's Valuation Ratios ENZY's Financial Strength Ratios ENZY's Gross Profit Growth
ENZY's Roa ENZY's Inventory Turnover Ratio ENZY's Growth Rates ENZY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2016, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2016 MRQ Gross ProfitDec 31 2016 MRQ Revenue
Agenus Inc  100.00 %$ 5.576  Millions$ 5.576  Millions
Seagen Inc   92.50 %$ 97.379  Millions$ 105.275  Millions
Biogen Inc   86.82 %$ 2,493.500  Millions$ 2,872.000  Millions
Voyager Therapeutics Inc   85.77 %$ 2.026  Millions$ 2.362  Millions
Gilead Sciences Inc   83.89 %$ 6,141.000  Millions$ 7,320.000  Millions
Cyclo Therapeutics Inc   83.66 %$ 0.441  Millions$ 0.528  Millions
Vivosim Labs Inc   81.58 %$ 0.939  Millions$ 1.151  Millions
Regenxbio Inc   80.54 %$ 1.366  Millions$ 1.696  Millions
Acorda Therapeutics Inc   78.41 %$ 110.258  Millions$ 140.626  Millions
Amgen Inc   77.05 %$ 4,596.000  Millions$ 5,965.000  Millions
Biocryst Pharmaceuticals Inc   74.43 %$ 6.686  Millions$ 8.983  Millions
Xtant Medical Holdings Inc   71.55 %$ 17.509  Millions$ 24.470  Millions
Nanostring Technologies Inc   66.59 %$ 16.803  Millions$ 25.232  Millions
Bio techne Corp  64.55 %$ 85.082  Millions$ 131.807  Millions
Exelixis Inc   64.53 %$ 50.064  Millions$ 77.581  Millions
Vericel Corporation  64.07 %$ 14.961  Millions$ 23.350  Millions
Enzymotec Ltd.  62.87 %$ 29.987  Millions$ 47.696  Millions
Ds Healthcare Group, Inc.  61.42 %$ 1.905  Millions$ 3.102  Millions
Fresh Tracks Therapeutics Inc   61.08 %$ 1.932  Millions$ 3.163  Millions
China Biologic Products Holdings Inc   60.25 %$ 46.773  Millions$ 77.635  Millions
Enzo Biochem Inc  57.91 %$ 15.208  Millions$ 26.260  Millions
Cellular Biomedicine Group Inc   57.62 %$ 0.033  Millions$ 0.058  Millions
Repligen Corp  52.49 %$ 13.438  Millions$ 25.600  Millions
Adma Biologics Inc   39.47 %$ 1.313  Millions$ 3.328  Millions
Halozyme Therapeutics Inc   13.90 %$ 5.420  Millions$ 39.003  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.